Veracyte
VCYT
$21.09
Share price
0.81%
Change (1 day)
-6.81%
Change (1 year)
Categories
Operating Margin for Veracyte (VCYT)
Operating Margin as of May 2024 (TTM): -11.67%
According to Veracyte's latest financial reports and stock price the company's current Operating Margin is -11.67%. At the end of 2022 the company had an Operating Margin of -12.28%.
Operating Margin history for Veracyte from 2013 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -12.28% | -66.97% |
| 2021 | -37.20% | 25.18% |
| 2020 | -29.71% | 183.88% |
| 2019 | -10.47% | -58.13% |
| 2018 | -25.00% | -41.99% |
| 2017 | -43.09% | -10.57% |
| 2016 | -48.18% | -29.24% |
| 2015 | -68.08% | -11.48% |
| 2014 | -76.91% | -34.2% |
| 2013 | -116.89% | -27.12% |
| 2012 | -160.38% | -70.63% |
| 2011 | -546.12% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Exact Sciences EXAS | -30.34% | 159.98% | 🇺🇸 USA |
 Myriad Genetics MYGN | -20.72% | 77.55% | 🇺🇸 USA |
 Biocept
BIOC | -124.57% | 967.44% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.